T. Rowe Price Associates
TBI

T. Rowe Price Associates’s Trueblue TBI Stock Holding History

T. Rowe Price Associates’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Buy
53,898
+6,939
+15% +$38.7K ﹤0.01% 2755
2026
Q1 		$184K Sell
46,959
-10,000
-18% -$44.4K ﹤0.01% 2871
2025
Q4 		$260K Buy
56,959
+6,400
+13% +$32.8K ﹤0.01% 2715
2025
Q3 		$310K Hold
50,559
– – ﹤0.01% 2589
2025
Q2 		$328K Sell
50,559
-12,218
-19% -$65.8K ﹤0.01% 2493
2025
Q1 		$334K Buy
62,777
+13,476
+27% +$92K ﹤0.01% 2418
2024
Q4 		$415K Buy
49,301
+11,248
+30% +$86.9K ﹤0.01% 2364
2024
Q3 		$301K Buy
38,053
+215
+0.6% +$1.93K ﹤0.01% 2476
2024
Q2 		$390K Buy
37,838
+855
+2% +$9.26K ﹤0.01% 2291
2024
Q1 		$464K Buy
36,983
+7,417
+25% +$95.9K ﹤0.01% 2239
2023
Q4 		$454K Sell
29,566
-23,947
-45% -$335K ﹤0.01% 2221
2023
Q3 		$786K Buy
53,513
+2,907
+6% +$45.3K ﹤0.01% 1905
2023
Q2 		$897K Buy
50,606
+31,236
+161% +$530K ﹤0.01% 1867
2023
Q1 		$345K Buy
19,370
+6,813
+54% +$127K ﹤0.01% 2279
2022
Q4 		$246K Sell
12,557
-10,511
-46% -$213K ﹤0.01% 2452
2022
Q3 		$441K Buy
23,068
+1,942
+9% +$39.3K ﹤0.01% 2185
2022
Q2 		$378K Buy
21,126
+69
+0.3% +$1.62K ﹤0.01% 2338
2022
Q1 		$608K Buy
21,057
+711
+3% +$19.5K ﹤0.01% 2254
2021
Q4 		$563K Buy
20,346
+3,170
+18% +$89.7K ﹤0.01% 2330
2021
Q3 		$465K Buy
17,176
+126
+0.7% +$3.37K ﹤0.01% 2408
2021
Q2 		$479K Sell
17,050
-13,634
-44% -$363K ﹤0.01% 2411
2021
Q1 		$676K Buy
30,684
+113
+0.4% +$2.32K ﹤0.01% 2229
2020
Q4 		$571K Buy
30,571
+8,285
+37% +$149K ﹤0.01% 2187
2020
Q3 		$345K Hold
22,286
– – ﹤0.01% 2237
2020
Q2 		$340K Sell
22,286
-94
-0.4% -$1.4K ﹤0.01% 2204
2020
Q1 		$286K Buy
22,380
+238
+1% +$4.26K ﹤0.01% 2204
2019
Q4 		$533K Buy
22,142
+1,508
+7% +$34.4K ﹤0.01% 2128
2019
Q3 		$435K Buy
20,634
+240
+1% +$4.96K ﹤0.01% 2150
2019
Q2 		$450K Hold
20,394
– – ﹤0.01% 2148
2019
Q1 		$482K Buy
20,394
+150
+0.7% +$3.5K ﹤0.01% 2127
2018
Q4 		$450K Buy
20,244
+7,367
+57% +$177K ﹤0.01% 2112
2018
Q3 		$335K Buy
12,877
+246
+2% +$6.83K ﹤0.01% 2316
2018
Q2 		$340K Sell
12,631
-3,856
-23% -$102K ﹤0.01% 2304
2018
Q1 		$427K Buy
16,487
+80
+0.5% +$2.19K ﹤0.01% 2141
2017
Q4 		$451K Sell
16,407
-10
-0.1% -$265 ﹤0.01% 2126
2017
Q3 		$369K Buy
16,417
+4,800
+41% +$109K ﹤0.01% 2203
2017
Q2 		$308K Hold
11,617
– – ﹤0.01% 2237
2017
Q1 		$318K Buy
11,617
+7
+0.1% +$179 ﹤0.01% 2233
2016
Q4 		$286K Hold
11,610
– – ﹤0.01% 2271
2016
Q3 		$263K Hold
11,610
– – ﹤0.01% 2265
2016
Q2 		$220K Hold
11,610
– – ﹤0.01% 2292
2016
Q1 		$304K Hold
11,610
– – ﹤0.01% 2148
2015
Q4 		$299K Buy
11,610
+110
+1% +$2.97K ﹤0.01% 2158
2015
Q3 		$258K Hold
11,500
– – ﹤0.01% 2192
2015
Q2 		$344K Hold
11,500
– – ﹤0.01% 2148
2015
Q1 		$280K Hold
11,500
– – ﹤0.01% 2219
2014
Q4 		$256K Hold
11,500
– – ﹤0.01% 2248
2014
Q3 		$290K Hold
11,500
– – ﹤0.01% 2166
2014
Q2 		$317K Hold
11,500
– – ﹤0.01% 2158
2014
Q1 		$336K Hold
11,500
– – ﹤0.01% 2111
2013
Q4 		$296K Hold
11,500
– – ﹤0.01% 2143
2013
Q3 		$276K Hold
11,500
– – ﹤0.01% 2138
2013
Q2 		$242K Buy
+11,500
New +$248K ﹤0.01% 2146

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IH
IES Holdings Houston, Texas $311M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates's TBI Position: Q2 2026 in Review

T. Rowe Price Associates increased its Trueblue (TBI) stake by 15% in Q2 2026, buying an estimated $38.7K and bringing the position to 53,898 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #2755.

T. Rowe Price Associates first reported a position in TBI in Q2 2013 and has held it in 53 quarters since. The position peaked at $897K in Q2 2023. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • T. Rowe Price Associates held 53,898 shares of Trueblue worth $376K as of Q2 2026.
  • T. Rowe Price Associates bought 6,939 Trueblue shares in Q2 2026, an estimated $38.7K.
  • Trueblue made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2755 holding.
  • T. Rowe Price Associates first reported a position in Trueblue in Q2 2013 and has held it in 53 quarters since.
  • T. Rowe Price Associates's Trueblue position peaked at $897K in Q2 2023.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.